Spanish study confirms albuminuria testing need
This article was originally published in Clinica
Microalbuminuria testing is underused in Spain and should be adopted as a routine procedure by cardiologists to assess the risk of renal and vascular complications. So say experts in response to a national cardiopathy study involving 2,740 diabetic and non-diabetic patients, amid evidence that the test is "rarely requested as a matter of routine assessment".
You may also be interested in...
ConMed Corp. is company of two halves ̶ general surgery and orthopedics – and is readying itself for a renewed assault on these two markets on the back of a technology pipeline, targeted acquisitions and a new growth-winning culture, says CFO Todd Garner.
Drug pricing and access issues expose the pharmaceutical sector especially acutely to calls for companies to meet ethical and social goals, alongside commercial ones. Digital is up-ending pharma’s processes, its workplaces and its consumers. R&D productivity is spluttering. Amid this turmoil, CEOs highlight company culture – the way an organization behaves – as a crucial ingredient for success. But what is a “right” culture? Organizational culture is neither static nor singular. It is continuously influenced by acquisitions, markets, new technologies and new generations. And pharma’s history suggests that culture change cannot happen without sufficient people change.